By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Expression Pathology said today that Roche will use its Liquid Tissue - SRM technology to identify molecular markers as part of its oncology drug programs.

The Rockville, Md.-based company said that it will provide Roche with multiplexed quantitative assays of cancer signaling pathway proteins and support their activation in formalin-fixed, paraffin-embedded samples for mass spectrometry analysis.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.